These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 9734530)

  • 1. Chickenpox immunisation in New Zealand.
    Tobias M; Reid S; Lennon D; Meech R; Teele DW
    N Z Med J; 1998 Jul; 111(1070):274-81. PubMed ID: 9734530
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chickenpox vaccines: new drugs. A favourable risk-benefit balance in some situations.
    Prescrire Int; 2005 Jun; 14(77):85-91. PubMed ID: 15977369
    [TBL] [Abstract][Full Text] [Related]  

  • 3. One dose of varicella vaccine does not prevent school outbreaks: is it time for a second dose?
    Lopez AS; Guris D; Zimmerman L; Gladden L; Moore T; Haselow DT; Loparev VN; Schmid DS; Jumaan AO; Snow SL
    Pediatrics; 2006 Jun; 117(6):e1070-7. PubMed ID: 16740809
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevention of varicella: recommendations for use of varicella vaccines in children, including a recommendation for a routine 2-dose varicella immunization schedule.
    American Academy of Pediatrics Committee on Infectious Diseases
    Pediatrics; 2007 Jul; 120(1):221-31. PubMed ID: 17606582
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Varicella vaccination in Australia and New Zealand.
    Macartney KK; Burgess MA
    J Infect Dis; 2008 Mar; 197 Suppl 2():S191-5. PubMed ID: 18419396
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Should the chickenpox vaccine be included in the National Immunization Schedule in India?
    Verma R; Bairwa M; Chawla S; Prinja S; Rajput M
    Hum Vaccin; 2011 Aug; 7(8):874-7. PubMed ID: 21791972
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Varicella vaccine and infection with varicella-zoster virus.
    Vázquez M; Shapiro ED
    N Engl J Med; 2005 Feb; 352(5):439-40. PubMed ID: 15689581
    [No Abstract]   [Full Text] [Related]  

  • 8. Varicella outbreak epidemiology in an active surveillance site, 1995-2005.
    Civen R; Lopez AS; Zhang J; Garcia-Herrera J; Schmid DS; Chaves SS; Mascola L
    J Infect Dis; 2008 Mar; 197 Suppl 2():S114-9. PubMed ID: 18419383
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Varicella outbreak reporting, response, management, and national surveillance.
    Leung J; Rue A; Lopez A; Ortega-Sanchez IR; Harpaz R; Guris D; Seward JF
    J Infect Dis; 2008 Mar; 197 Suppl 2():S108-13. PubMed ID: 18419382
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Incorporation of varicella-zoster virus vaccination in childhood immunization schedules].
    Rothbart H; Rishpon S
    Harefuah; 2008; 147(8-9):693-7, 751, 750. PubMed ID: 18935757
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunogenicity of a two-dose regime of varicella vaccine in children with cancers.
    Leung TF; Li CK; Hung EC; Chan PK; Mo CW; Wong RP; Chik KW
    Eur J Haematol; 2004 May; 72(5):353-7. PubMed ID: 15059071
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Varicella vaccine].
    Abarca Villaseca K
    Rev Chilena Infectol; 2006 Mar; 23(1):56-9. PubMed ID: 16462966
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevention strategies: experience of varicella vaccination programmes.
    Patrick D
    Herpes; 2007 Sep; 14 Suppl 2():48-51. PubMed ID: 17939897
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Review of the Varilrix varicella vaccine.
    Chiu SS; Lau YL
    Expert Rev Vaccines; 2005 Oct; 4(5):629-43. PubMed ID: 16221065
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Modelling the impact of vaccination on the epidemiology of varicella zoster virus].
    Bonmarin I; Santa-Olalla P; Lévy-Bruhl D
    Rev Epidemiol Sante Publique; 2008 Oct; 56(5):323-31. PubMed ID: 18951741
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Varicella vaccine].
    Bégué P
    Arch Pediatr; 1999 Sep; 6(9):1005-9. PubMed ID: 10519038
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Varicella among adults: data from an active surveillance project, 1995-2005.
    Marin M; Watson TL; Chaves SS; Civen R; Watson BM; Zhang JX; Perella D; Mascola L; Seward JF
    J Infect Dis; 2008 Mar; 197 Suppl 2():S94-S100. PubMed ID: 18419417
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Humoral and cell-mediated immune responses in children and adults after 1 and 2 doses of varicella vaccine.
    Watson B
    J Infect Dis; 2008 Mar; 197 Suppl 2():S143-6. PubMed ID: 18419388
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Safety and efficacy of varicella vaccine in healthy children--one year follow-up].
    Jackowska T; Dziadek J; Wasilewski R; Wasik M
    Med Wieku Rozwoj; 2008; 12(2 Pt 2):653-9. PubMed ID: 19418940
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunogenicity and safety assessments after one and two doses of a refrigerator-stable tetravalent measles-mumps-rubella-varicella vaccine in healthy children during the second year of life.
    Schuster V; Otto W; Maurer L; Tcherepnine P; Pfletschinger U; Kindler K; Soemantri P; Walther U; Macholdt U; Douha M; Pierson P; Willems P
    Pediatr Infect Dis J; 2008 Aug; 27(8):724-30. PubMed ID: 18600190
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.